Crystalline Silica Surface Modification via Co-Grinding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for modifying crystalline silicon dioxide surfaces to reduce their cytotoxic and pro-inflammatory potential have not been sufficiently effective, particularly in retaining technologically important properties like good wetting by aqueous solutions.

Innovation Solution

A process involving grinding crystalline silicon dioxide with 0.05 to 1.00% by weight of substances such as polyhydric alcohols, kaolin, or aluminum alcoholates, which react with the freshly generated surface to reduce reactive silanol groups and thereby decrease biological activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If crystalline silicon dioxide surfaces are modified to reduce cytotoxic and pro-inflammatory potential, then biological safety is improved, but technologically important properties such as wetting by aqueous solutions deteriorate

Engineering Contradiction:
Improvecytotoxic and pro-inflammatory potentialVSAvoidwetting by aqueous solutions
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

The patent applies local quality by selectively modifying only the surface layer of crystalline silicon dioxide particles through co-grinding with specific substances (polyhydric alcohols, kaolin, or aluminum alcoholates). This creates a surface-specific modification that reduces cytotoxicity and pro-inflammatory potential through reaction with reactive silanol groups, while preserving the bulk material's technologically important properties including wetting characteristics. The modification is localized to the surface where biological interaction occurs, rather than altering the entire particle structure.

Inventive Principle:
Principle #3Local quality

2Object-affected harmful factors

If reactive silanol groups on SiO2 surface are deactivated to reduce pathological effects, then health risk is reduced, but surface reactivity and technological functionality are compromised

Engineering Contradiction:
Improvepathological effectsVSAvoidsurface reactivity
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by controlling the concentration of modifying substances (0.05 to 1.00% by weight) and the grinding conditions to achieve optimal deactivation of reactive silanol groups. This quantitative control allows sufficient reduction of pathological effects while maintaining adequate surface reactivity for technological applications. The specific parameter range ensures that not all silanol groups are deactivated, preserving necessary surface functionality.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If surface modification is performed to reduce biological activity, then safety is improved, but process complexity increases

Engineering Contradiction:
Improvebiological activityVSAvoidprocess complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent applies merging by combining the surface modification step with the existing grinding process. The modifying substances (polyhydric alcohols, kaolin, or aluminum alcoholates) are introduced directly into the grinding mill along with the crystalline silicon dioxide, allowing simultaneous size reduction and surface modification in a single operation. This integration eliminates the need for separate modification steps, reducing overall process complexity while achieving the safety improvements.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process effectively reduces the cytotoxic and pro-inflammatory potential of crystalline silicon dioxide while maintaining its technologically important properties, as demonstrated by reduced LDH release and Cxcl2 gene expression in in-vitro tests.

Implementation Method 1

grinding a crystalline silicon dioxide together with from 0.05 to 1.00% by weight of a substance selected from the group consisting of polyhydric alcohols, kaolin, aluminum alcoholates, and mixtures thereof

Methodology Applied
Scientific EffectSurface reaction: Chemical Bonding

Implementation Method 2

react with the freshly generated surface to reduce reactive silanol groups

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS12325640B2Sequestering of crystalline silicon dioxide
Publication Date: 2025.06.10 QUARZWERKE GMBH
  • US12325640B2 patent drawing
  • US12325640B2 patent drawing

AI summary

A process for treating crystalline silicon dioxide, comprising the step of grinding a crystalline silicon dioxide together with from 0.05 to 1.00% by weight of a substance selected from the group consisting of polyhydric alcohols, kaolin, aluminum alcoholates, and mixtures thereof.